The following data is part of a premarket notification filed by Biomet, Inc. with the FDA for Vanguard Xp Femoral Component(gen Ii)/vanguard Xp Femoral Trial.
Device ID | K141407 |
510k Number | K141407 |
Device Name: | VANGUARD XP FEMORAL COMPONENT(GEN II)/VANGUARD XP FEMORAL TRIAL |
Classification | Prosthesis, Knee, Patello/femorotibial, Semi-constrained, Uncemented, Porous, Coated, Polymer/metal/polymer |
Applicant | BIOMET, INC. 56 EAST BELL DR. BOX 587 Warsaw, IN 46581 -0587 |
Contact | Julie Gantenberg, M.s. |
Correspondent | Julie Gantenberg, M.s. BIOMET, INC. 56 EAST BELL DR. BOX 587 Warsaw, IN 46581 -0587 |
Product Code | MBH |
Subsequent Product Code | JWH |
Subsequent Product Code | MBV |
Subsequent Product Code | OIY |
CFR Regulation Number | 888.3565 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2014-05-28 |
Decision Date | 2014-10-27 |
Summary: | summary |